TY - JOUR
T1 - Germany’s digital health reforms in the COVID-19 era
T2 - lessons and opportunities for other countries
AU - Gerke, Sara
AU - Stern, Ariel D.
AU - Minssen, Timo
N1 - Publisher Copyright:
© 2020, The Author(s).
PY - 2020/12/1
Y1 - 2020/12/1
N2 - Reimbursement is a key challenge for many new digital health solutions, whose importance and value have been highlighted and expanded by the current COVID-19 pandemic. Germany’s new Digital Healthcare Act (Digitale–Versorgung–Gesetz or DVG) entitles all individuals covered by statutory health insurance to reimbursement for certain digital health applications (i.e., insurers will pay for their use). Since Germany, like the United States (US), is a multi-payer health care system, the new Act provides a particularly interesting case study for US policymakers. We first provide an overview of the new German DVG and outline the landscape for reimbursement of digital health solutions in the US, including recent changes to policies governing telehealth during the COVID-19 pandemic. We then discuss challenges and unanswered questions raised by the DVG, ranging from the limited scope of the Act to privacy issues. Lastly, we highlight early lessons and opportunities for other countries.
AB - Reimbursement is a key challenge for many new digital health solutions, whose importance and value have been highlighted and expanded by the current COVID-19 pandemic. Germany’s new Digital Healthcare Act (Digitale–Versorgung–Gesetz or DVG) entitles all individuals covered by statutory health insurance to reimbursement for certain digital health applications (i.e., insurers will pay for their use). Since Germany, like the United States (US), is a multi-payer health care system, the new Act provides a particularly interesting case study for US policymakers. We first provide an overview of the new German DVG and outline the landscape for reimbursement of digital health solutions in the US, including recent changes to policies governing telehealth during the COVID-19 pandemic. We then discuss challenges and unanswered questions raised by the DVG, ranging from the limited scope of the Act to privacy issues. Lastly, we highlight early lessons and opportunities for other countries.
UR - http://www.scopus.com/inward/record.url?scp=85087753439&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087753439&partnerID=8YFLogxK
U2 - 10.1038/s41746-020-0306-7
DO - 10.1038/s41746-020-0306-7
M3 - Review article
C2 - 32685700
AN - SCOPUS:85087753439
SN - 2398-6352
VL - 3
JO - npj Digital Medicine
JF - npj Digital Medicine
IS - 1
M1 - 94
ER -